DC Advisory advised 1mg Technologies on a £70m Series D investment from Corisol Holdings, IFC and others

Background

• 1MG Technologies, India's leading integrated health-tech platform, focuses on providing Indian consumers with access to an integrated health-tech platform to better manage their health
• The platform includes information, products, services and health tools

Process

• DC Advisory India acted as exclusive financial advisor to 1MG Technologies on its $70m Series D fund raise from Corisol Holdings AG (largest shareholder of Zur Rose AG, Europe’s leading ePharmacy group), International Finance Corporation (investment arm of the World Bank), and a high quality investor group from South Korea. Existing investors of 1MG, Maverick Ventures, HBM Healthcare, Sequoia Capital, Omidyar Network and Kae Capital, also participated in this Series D financing round

Outcome

• This financing will allow 1MG to grow aggressively by expanding its geographical presence, accelerating its move towards a full stack supply chain model, developing ecosystem partnerships and building AI / ML tools which will enable the company to provide better healthcare services to its customers

Team DC Advisory was a pleasure to work with. They worked tenaciously throughout the process and their sector knowledge, global access and professionalism was helpful to creating the desired outcome for all stakeholders. We are very excited about the opportunity in front of us to scale our business aggressively and thank the DC Advisory team for their support throughout this transaction.